Literature DB >> 21301980

Production of monoclonal antibodies against antitumor cyclohexapeptide RA-VII from Rubia cordifolia and their characterization.

Tomoyo Hasuda1, Yukio Hitotsuyanagi, Koichi Takeya.   

Abstract

An immunoassay system was established for the estimation of the quantity of an antitumor cyclic hexapeptide RA-VII (1) from Rubia cordifolia L. and R. akane Nakai (Rubiaceae). First, 1 was converted into its hapten, which was then conjugated with a carrier protein to be used as an effective antigen to obtain its monoclonal antibody (MAb). In the resulting conjugate, the molecular ratio between 1 and the carrier protein as assayed by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) was about 5:1. Then, the splenocytes from the mouse immunized with the conjugate were fused with mouse myeloma cells to produce hybridoma, secreting MAb against 1. Two clones were isolated, one producing MAb IgG(1) and the other IgM, both having a κ light chain. The sensitivity and cross-reactivity of the thus obtained MAb were also assayed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301980     DOI: 10.1007/s11418-011-0508-z

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  13 in total

1.  RA-VII, a cyclic depsipeptide, changes the conformational structure of actin to cause G2 arrest by the inhibition of cytokinesis.

Authors:  Hironori Fujiwara; Shin-ya Saito; Yukio Hitotsuyanagi; Koichi Takeya; Yasushi Ohizumi
Journal:  Cancer Lett       Date:  2004-06-25       Impact factor: 8.679

2.  Production of monoclonal antibodies and ELISA for thebaine and codeine.

Authors:  Y Shoyama; T Fukada; H Murakami
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

3.  Production of monoclonal antibodies and development of an ELISA for solamargine.

Authors:  M Ishiyama; Y Shoyama; H Murakami; H Shinohara
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

4.  Formation of a monoclonal antibody against glycyrrhizin and development of an ELISA.

Authors:  H Tanaka; Y Shoyama
Journal:  Biol Pharm Bull       Date:  1998-12       Impact factor: 2.233

5.  Rapid analysis of small samples containing forskolin using monoclonal antibodies.

Authors:  H Yanagihara; R Sakata; Y Shoyama; H Murakami
Journal:  Planta Med       Date:  1996-04       Impact factor: 3.352

6.  Studies on the antitumor cyclic hexapeptides obtained from Rubiae radix.

Authors:  H Itokawa; K Takeya; K Mihara; N Mori; T Hamanaka; T Sonobe; Y Iitaka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-04       Impact factor: 1.645

7.  Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix.

Authors:  H Itokawa; K Takeya; N Mori; T Hamanaka; T Sonobe; K Mihara
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-01       Impact factor: 1.645

8.  Bouvardin and deoxybouvardin, antitumor cyclic hexapeptides from Bouvardia ternifolia (Rubiaceae).

Authors:  S D Jolad; J J Hoffmann; S J Torrance; R M Wiedhopf; J R Cole; S K Arora; R B Bates; R L Gargiulo; G R Kriek
Journal:  J Am Chem Soc       Date:  1977-11-23       Impact factor: 15.419

9.  Monoclonal antibody based enzyme immunoassay for marihuana (cannabinoid) compounds.

Authors:  H Tanaka; Y Goto; Y Shoyama
Journal:  J Immunoassay       Date:  1996-11

10.  Production of monoclonal antibodies and enzyme immunoassay for typical adenylate cyclase activator, Forskolin.

Authors:  R Sakata; Y Shoyama; H Murakami
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

View more
  1 in total

1.  Structural and bioactive studies of terpenes and cyclopeptides from the Genus Rubia.

Authors:  Kuo Xu; Penglong Wang; Bin Yuan; Yatao Cheng; Qiang Li; Haimin Lei
Journal:  Chem Cent J       Date:  2013-05-04       Impact factor: 4.215

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.